Literature DB >> 20947372

Cigarette smoking women of reproductive age who use oral contraceptives: results from the 2002 and 2004 behavioral risk factor surveillance systems.

Annette K McClave1, Carol J Hogue, Larissa R Brunner Huber, Alexandra C Ehrlich.   

Abstract

BACKGROUND: Despite health warnings about the increased risk of cerebrovascular disease among women who smoke while using oral contraceptives (OCs), prior research suggests that OC use is still prevalent among women who smoke cigarettes. Our objective was to investigate the prevalence of OC use among cigarette smoking women of reproductive age in the United States. STUDY
DESIGN: We extracted data from the 2002 and 2004 Behavioral Risk Factor Surveillance System surveys of 76,544 women between 18 and 44 years of age who reported using some form of contraception. OC use, or self-reported use of "the pill," was examined among those who currently smoke, either everyday or some days. Multivariable logistic regression models were used to compare OC use between smoking and nonsmoking women.
RESULTS: One fourth (26.9%) of U.S. women who smoke compared with 34.6% of nonsmoking women reported currently using OCs. After adjusting for age, race/ethnicity, marital status, education level, binge drinking, and health care coverage, women who smoke were 0.6 (95% confidence interval [CI], 0.6-0.7) times as likely to use OCs as nonsmoking women. Among women aged 35 to 44 years, the odds of OC use among smokers was even further reduced (odds ratio [OR], 0.3; 95% CI, 0.3-0.4) compared with nonsmokers.
CONCLUSION: Among U.S. women of reproductive age who use contraception, particularly among women aged 35 to 44 years, those who smoke cigarettes are significantly less likely to use OCs than those who do not. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947372     DOI: 10.1016/j.whi.2010.06.006

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  8 in total

Review 1.  Medical Eligibility for Contraception in Women at Increased Risk.

Authors:  Thomas Römer
Journal:  Dtsch Arztebl Int       Date:  2019-11-08       Impact factor: 5.594

2.  Hormonal contraceptive use in smokers: Prevalence of use and associations with smoking motives.

Authors:  Alicia M Allen; Kim Lundeen; Lynn E Eberly; Sharon S Allen; Mustafa al'Absi; Myra Muramoto; Dorothy Hatsukami
Journal:  Addict Behav       Date:  2017-10-13       Impact factor: 3.913

3.  Oral Contraceptives and Cigarette Smoking: A Review of the Literature and Future Directions.

Authors:  Alicia M Allen; Andrea H Weinberger; Reagan R Wetherill; Carol L Howe; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2019-04-17       Impact factor: 4.244

4.  The effect of combination oral contraceptives on smoking-related symptomatology during short-term smoking abstinence.

Authors:  Katie Hinderaker; Alicia M Allen; Nicole Tosun; Mustafa al'Absi; Dorothy Hatsukami; Sharon S Allen
Journal:  Addict Behav       Date:  2014-10-23       Impact factor: 3.913

5.  Oral contraceptives and nicotine synergistically exacerbate cerebral ischemic injury in the female brain.

Authors:  Ami P Raval; Raquel Borges-Garcia; Francisca Diaz; Thomas J Sick; Helen Bramlett
Journal:  Transl Stroke Res       Date:  2013-02-13       Impact factor: 6.829

6.  Use of hormonal contraceptives and smoking cessation: A preliminary report.

Authors:  Alicia M Allen; Samantha Carlson; Lynn E Eberly; Dorothy Hatsukami; Megan E Piper
Journal:  Addict Behav       Date:  2017-08-04       Impact factor: 3.913

7.  National, regional, and global prevalence of cigarette smoking among women/females in the general population: a systematic review and meta-analysis.

Authors:  Alireza Jafari; Abdolhalim Rajabi; Mahdi Gholian-Aval; Nooshin Peyman; Mehrsadat Mahdizadeh; Hadi Tehrani
Journal:  Environ Health Prev Med       Date:  2021-01-08       Impact factor: 3.674

8.  The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study.

Authors:  Ghadah A Assiri; Douha F Bannan; Ghadah H Alshehri; Manal Alshyhani; Walaa Almatri; Mansour A Mahmoud
Journal:  Int J Environ Res Public Health       Date:  2022-01-29       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.